Vol 52, No 5 (2018)
Published online: 2018-08-17

open access

Page views 300
Article views/downloads 446
Get Citation

Connect on Social Media

Connect on Social Media

Cerebral thrombolysis in patients with ischemic stroke and heart failure

Piotr Sobolewski12, Grzegorz Kozera3, Wiktor Szczuchniak2, Anna Sobota2, Kamil Chwojnicki4, Marcin Gruchała5, Walenty M. Nyka4
DOI: 10.1016/j.pjnns.2018.08.003
Neurol Neurochir Pol 2018;52(5):593-598.

Abstract

Background

Heart failure (HF) is common among patients with ischemic stroke (IS), however its impact on outcome after iv-thrombolysis has not been fully determined. Moreover, definition of HF has been recently modified, but majority of stroke studies classified patients regarding an old HF criteria. Thus, the aim of our study was to evaluate the relationship between both, newly and formerly defined HF and the long-term outcome, mortality and the presence of hemorrhagic complications in patients with acute IS treated with iv-thrombolysis.

Methods

We retrospectively evaluated data from 328 Caucasian patients with IS consecutively treated with iv-thrombolysis. HF was defined according to old and new definition; long-term outcome was assessed with modified Rankin Scale (mRS) score and mortality rate on 90th days after IS.

Results

The incidence of HF did not differ between patients with favorable (mRS 0–2) and unfavorable (mRS 3–6) functional outcome respectively for the old and for the new definition (10.4% vs. 15.5, p = 0.17; 17.4% vs. 18.1%, p = 0.88) and between those who survived and died within 90 days after IS (11.7% vs. 20.0%, p = 0.27; 17.2% vs. 25.0%, p = 0.38, respectively). Multivariate analysis showed no impact of HF diagnosis on outcome (p = 0.94) or mortality (p = 0.64).

Conclusion

The presence of systolic HF, defined according to an old and a new definition, does not determine safety and efficacy of cerebral iv-thrombolysis in patients with IS.

Article available in PDF format

View PDF Download PDF file